Marvelous™ is a state-of-the-art specialized flow-control stopcock used for the administration of IV procedures, including medications, or as a blood sampling port in hemodynamic monitoring sets. Due to its unique design, the Marvelous™ stopcock ensures maximum safety of patients and medical staff during medical procedures at hospital ICUs and at other critical care facilities and outpatient clinics.
Marvelous™ was developed by Elcam Medical Ltd., a leading manufacturer of flow-control medical equipment, with the intention of reducing the risk of infection caused by microbial colonization in stopcocks -- a prevalent and persistent threat in critical care facilities throughout the U.S. and Europe.
Currently, medical personnel use CVCs (central venous catheters) during the administration of IV fluids and medications, and for sampling blood. Each CVC may contain several stopcocks, thereby posing a severe risk of infections developing along entry points in the catheter tunnel, which can easily spread through the bloodstream or metastasize throughout the body. One of the sources of such type of infections is microbial colonization in “dead spaces” which, despite standard flushing procedures, cannot be completely cleared of fluid remnants. Colonization in this area is stimulated particularly while the catheter is connected to a blood vessel in a patient, with further contamination propelled by recurrent manipulation of the stopcock.
The Marvelous™ stopcock flushes automatically any fluids remaining inside the stopcock, assuring minimal residual volume, keeping the stopcock clean after blood sampling. This eliminates the risk of blood clotting and prevents bacterial colonization. In addition, an integrated luer-activated valve serves as a bacterial barrier, creating a closed circuit that is accessible without opening it to air. This further lowers the risk of microbial colonization inside the stopcocks, preventing catheter contamination and reducing the chance of infection. It also reduces the risk of needle stick injuries and prevents blood spillage, which is hazardous both for patients and medical staff alike.
Eliminating the need to use cannulas, needles or caps, the Marvelous™ stopcock reduces operational costs, and is simple to operate. Easily swab-able, minimizing the risk of air bubbles, stopcock manipulation is reduced, saving time while setting up a patient’s IV; adjusting a medication regimen in an IV line; or drawing blood.
The Marvelous™ stopcock additionally provides efficient pressure monitoring without signal damping, by assuring complete separation between the flow path and the valve by the handle.
“The novelty of the Marvelous™ stopcock is in its simple design, aimed at preventing microbial contamination. Our longstanding commitment to helping medical personnel worldwide in their relentless efforts to prevent healthcare-facility-acquired infections, has propelled us to develop innovative flow-control solutions that combine ergonomics with profound medical knowledge and understanding,” says David Ziv, vice president of marketing for Elcam Ltd.
Source: Elcam Medical
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.